{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T16:29:53Z","timestamp":1648657793822},"reference-count":35,"publisher":"Japanese Society of Toxicology","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2019]]},"DOI":"10.2131\/jts.44.535","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T22:06:01Z","timestamp":1564697161000},"page":"535-542","source":"Crossref","is-referenced-by-count":0,"title":["Disulfiram facilitates ataxin-3 nuclear translocation and potentiates the cytotoxicity in a cell model of SCA3"],"prefix":"10.2131","volume":"44","author":[{"given":"Zijian","family":"Wang","sequence":"first","affiliation":[{"name":"Genetic Engineering Laboratory, College of Biological and Environmental Engineering, Xi\u2019an University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Antony, P.M., M\u00e4ntele, S., Mollenkopf, P., Boy, J., Kehlenbach, R.H., Riess, O. and Schmidt, T. (2009): Identification and functional dissection of localization signals within ataxin-3. Neurobiol. Dis., <b>36<\/b>, 280-292.","DOI":"10.1016\/j.nbd.2009.07.020"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Berke, S.J., Schmied, F.A., Brunt, E.R., Ellerby, L.M. and Paulson, H.L. (2004): Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3. J. Neurochem., <b>89<\/b>, 908-918.","DOI":"10.1111\/j.1471-4159.2004.02369.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Bichelmeier, U., Schmidt, T., H\u00fcbener, J., Boy, J., R\u00fcttiger, L., H\u00e4big, K., Poths, S., Bonin, M., Knipper, M., Schmidt, W.J., Wilbertz, J., Wolburg, H., Laccone, F. and Riess, O. (2007): Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: <i>in vivo<\/i> evidence. J. Neurosci., <b>27<\/b>, 7418-7428.","DOI":"10.1523\/JNEUROSCI.4540-06.2007"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Bradford, M.M. (1976): A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., <b>72<\/b>, 248-254.","DOI":"10.1016\/0003-2697(76)90527-3"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Breuer, P., Haacke, A., Evert, B.O. and W\u00fcllner, U. (2010): Nuclear aggregation of polyglutamine-expanded ataxin-3: fragments escape the cytoplasmic quality control. J. Biol. Chem., <b>285<\/b>, 6532-6537.","DOI":"10.1074\/jbc.M109.036335"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Chen, D., Cui, Q.C., Yang, H. and Dou, Q.P. (2006): Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Cancer Res., <b>66<\/b>, 10425-10433.","DOI":"10.1158\/0008-5472.CAN-06-2126"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Cvek, B. and Dvorak, Z. (2008): The value of proteasome inhibition in cancer. Can the old drug, disulfiram, have a bright new future as a novel proteasome inhibitor? Drug Discov. Today, <b>13<\/b>, 716-722.","DOI":"10.1016\/j.drudis.2008.05.003"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Duarte-Silva, S., Neves-Carvalho, A., Soares-Cunha, C., Silva, J.M., Teixeira-Castro, A., Vieira, R., Silva-Fernandes, A. and Maciel, P. (2018): Neuroprotective effects of creatine in the CMVMJD135 mouse model of spinocerebellar ataxia type 3. Mov. Disord., <b>33<\/b>, 815-826.","DOI":"10.1002\/mds.27292"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Faiman, M.D., Jensen, J.C. and Lacoursiere, R.B. (1984): Elimination kinetics of disulfiram in alcoholics after single and repeated doses. Clin. Pharmacol. Ther., <b>36<\/b>, 520-526.","DOI":"10.1038\/clpt.1984.213"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Fernandez-Estevez, M.A., Casarejos, M.J., L\u00f3pez Sendon, J., Garcia Caldentey, J., Ruiz, C., Gomez, A., Perucho, J., de Yebenes, J.G. and Mena, M.A. (2014): Trehalose reverses cell malfunction in fibroblasts from normal and Huntington\u2019s disease patients caused by proteosome inhibition. PLoS One, <b>9<\/b>, e90202.","DOI":"10.1371\/journal.pone.0090202"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Fujigasaki, H., Uchihara, T., Koyano, S., Iwabuchi, K., Yagishita, S., Makifuchi, T., Nakamura, A., Ishida, K., Toru, S., Hirai, S., Ishikawa, K., Tanabe, T. and Mizusawa, H. (2000): Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains. Exp. Neurol., <b>165<\/b>, 248-256.","DOI":"10.1006\/exnr.2000.7479"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Grosso, H. and Mouradian, M.M. (2012): Transglutaminase 2: biology, relevance to neurodegenerative diseases and therapeutic implications. Pharmacol. Ther., <b>133<\/b>, 392-410.","DOI":"10.1016\/j.pharmthera.2011.12.003"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Kulkarni, R.R., Pradeep, A.V. and Bairy, B.K. (2013): Disulfiram-induced combined irreversible anterior ischemic optic neuropathy and reversible peripheral neuropathy: a prospective case report and review of the literature. J. Neuropsychiatry Clin. Neurosci., <b>25<\/b>, 339-342.","DOI":"10.1176\/appi.neuropsych.12120410"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Li, L., Yang, H., Chen, D., Cui, C. and Dou, Q.P. (2008): Disulfiram promotes the conversion of carcinogenic cadmium to a proteasome inhibitor with pro-apoptotic activity in human cancer cells. Toxicol. Appl. Pharmacol., <b>229<\/b>, 206-214.","DOI":"10.1016\/j.taap.2008.01.022"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Lin, Y., He, H., Luo, Y., Zhu, T. and Duan, R. (2015): Inhibition of transglutaminase exacerbates polyglutamine-induced neurotoxicity by increasing the aggregation of mutant ataxin-3 in an SCA3 Drosophila model. Neurotox. Res., <b>27<\/b>, 259-267.","DOI":"10.1007\/s12640-014-9506-8"},{"key":"16","doi-asserted-by":"crossref","unstructured":"L\u00f6vborg, H., Oberg, F., Rickardson, L., Gullbo, J., Nygren, P. and Larsson, R. (2006): Inhibition of proteasome activity, nuclear factor-KappaB translocation and cell survival by the antialcoholism drug disulfiram. Int. J. Cancer, <b>118<\/b>, 1577-1580.","DOI":"10.1002\/ijc.21534"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Mueller, T., Breuer, P., Schmitt, I., Walter, J., Evert, B.O. and W\u00fcllner, U. (2009): CK2-dependent phosphorylation determines cellular localization and stability of ataxin-3. Hum. Mol. Genet., <b>18<\/b>, 3334-3343.","DOI":"10.1093\/hmg\/ddp274"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Palanski, B.A. and Khosla, C. (2018): Cystamine and Disulfiram Inhibit Human Transglutaminase 2 via an Oxidative Mechanism. Biochemistry, <b>57<\/b>, 3359-3363.","DOI":"10.1021\/acs.biochem.8b00204"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Pastori, V., Sangalli, E., Coccetti, P., Pozzi, C., Nonnis, S., Tedeschi, G. and Fusi, P. (2010): CK2 and GSK3 phosphorylation on S29 controls wild-type ATXN3 nuclear uptake. Biochim. Biophys. Acta, <b>1802<\/b>, 583-592.","DOI":"10.1016\/j.bbadis.2010.03.007"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Paulson, H.L., Das, S.S., Crino, P.B., Perez, M.K., Patel, S.C., Gotsdiner, D., Fischbeck, K.H. and Pittman, R.N. (1997): Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain. Ann. Neurol., <b>41<\/b>, 453-462.","DOI":"10.1002\/ana.410410408"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Paulson, H.L., Shakkottai, V.G., Clark, H.B. and Orr, H.T. (2017): Polyglutamine spinocerebellar ataxias - from genes to potential treatments. Nat. Rev. Neurosci., <b>18<\/b>, 613-626.","DOI":"10.1038\/nrn.2017.92"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Pav\u00f3n, N., Buelna-Chontal, M., Correa, F., Yoval-S\u00e1nchez, B., Belmont, J., Hern\u00e1ndez-Esquivel, L., Rodr\u00edguez-Zavala, J.S. and Ch\u00e1vez, E. (2017): Tamoxifen inhibits mitochondrial membrane damage caused by disulfiram. Biochem. Cell Biol., <b>95<\/b>, 556-562.","DOI":"10.1139\/bcb-2017-0027"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Reina, C.P., Zhong, X. and Pittman, R.N. (2010): Proteotoxic stress increases nuclear localization of ataxin-3. Hum. Mol. Genet., <b>19<\/b>, 235-249.","DOI":"10.1093\/hmg\/ddp482"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Saute, J.A. and Jardim, L.B. (2015): Machado Joseph disease: clinical and genetic aspects, and current treatment. Expert Opin. Orphan Drugs, <b>3<\/b>, 517-535.","DOI":"10.1517\/21678707.2015.1025747"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Schmidt, T., Landwehrmeyer, G.B., Schmitt, I., Trottier, Y., Auburger, G., Laccone, F., Klockgether, T., V\u00f6lpel, M., Epplen, J.T., Sch\u00f6ls, L. and Riess, O. (1998): An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patients. Brain Pathol., <b>8<\/b>, 669-679.","DOI":"10.1111\/j.1750-3639.1998.tb00193.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Schulman, B.A. and Harper, J.W. (2009): Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways. Nat. Rev. Mol. Cell Biol., <b>10<\/b>, 319-331.","DOI":"10.1038\/nrm2673"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Skrott, Z., Mistrik, M., Andersen, K.K., Friis, S., Majera, D., Gursky, J., Ozdian, T., Bartkova, J., Turi, Z., Moudry, P., Kraus, M., Michalova, M., Vaclavkova, J., Dzubak, P., Vrobel, I., Pouckova, P., Sedlacek, J., Miklovicova, A., Kutt, A., Li, J., Mattova, J., Driessen, C., Dou, Q.P., Olsen, J., Hajduch, M., Cvek, B., Deshaies, R.J. and Bartek, J. (2017): Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. Nature, <b>552<\/b>, 194-199.","DOI":"10.1038\/nature25016"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Sowa, A.S., Martin, E., Martins, I.M., Schmidt, J., Depping, R., Weber, J.J., Rother, F., Hartmann, E., Bader, M., Riess, O., Tricoire, H. and Schmidt, T. (2018): Karyopherin \u03b1-3 is a key protein in the pathogenesis of spinocerebellar ataxia type 3 controlling the nuclear localization of ataxin-3. Proc. Natl. Acad. Sci. USA, <b>115<\/b>, E2624-E2633.","DOI":"10.1073\/pnas.1716071115"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Stone, S.L., Cartwright, M.S., Panea, O.R., Vann, R.C., Magruder, J.L. and Walker, F.O. (2014): Neuromuscular ultrasound findings in polyneuropathy secondary to disulfiram. J. Clin. Neurophysiol., <b>31<\/b>, e18-e20.","DOI":"10.1097\/WNP.0000000000000101"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Sun, J., Xu, H., Negi, S., Subramony, S.H. and Hebert, M.D. (2007): Differential effects of polyglutamine proteins on nuclear organization and artificial reporter splicing. J. Neurosci. Res., <b>85<\/b>, 2306-2317.","DOI":"10.1002\/jnr.21369"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Wade, B.E., Wang, C.E., Yan, S., Bhat, K., Huang, B., Li, S. and Li, X.J. (2014): Ubiquitin-activating enzyme activity contributes to differential accumulation of mutant huntingtin in brain and peripheral tissues. J. Neurosci., <b>34<\/b>, 8411-8422.","DOI":"10.1523\/JNEUROSCI.0775-14.2014"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Wang, Z.J., Hanet, A., Weish\u00e4upl, D., Martins, I.M., Sowa, A.S., Riess, O. and Schmidt, T. (2018): Divalproex sodium modulates nuclear localization of ataxin-3 and prevents cellular toxicity caused by expanded ataxin-3. CNS Neurosci. Ther., <b>24<\/b>, 404-411.","DOI":"10.1111\/cns.12795"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Wanker, E.E., Scherzinger, E., Heiser, V., Sittler, A., Eickhoff, H. and Lehrach, H. (1999): Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates. Methods Enzymol., <b>309<\/b>, 375-386.","DOI":"10.1016\/S0076-6879(99)09026-6"},{"key":"34","doi-asserted-by":"publisher","unstructured":"Weber, J.J., Golla, M., Guaitoli, G., Wanichawan, P., Hayer, S.N., Hauser, S., Krahl, A.C., Nagel, M., Samer, S., Aronica, E., Carlson, C.R., Sch\u00f6ls, L., Riess, O., Gloeckner, C.J., Nguyen, H.P. and H\u00fcbener-Schmid, J. (2017): A combinatorial approach to identify calpain cleavage sites in the Machado-Joseph disease protein ataxin-3. Brain, <b>140<\/b>, 1280-1299.","DOI":"10.1093\/brain\/awx039"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Xu, B., Wang, S., Li, R., Chen, K., He, L., Deng, M., Kannappan, V., Zha, J., Dong, H. and Wang, W. (2017): Disulfiram\/copper selectively eradicates AML leukemia stem cells <i>in vitro<\/i> and <i>in vivo<\/i> by simultaneous induction of ROS-JNK and inhibition of NF-\u03baB and Nrf2. Cell Death Dis., <b>8<\/b>, e2797.","DOI":"10.1038\/cddis.2017.176"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/44\/8\/44_535\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T03:25:39Z","timestamp":1564802739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/44\/8\/44_535\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.44.535","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}